hotspot -WSS

hotspot

author：focus 2025-09-06 03:52:56 - browse：5

Capitol Riot Maine — FILE - Violent rioters supporting President Donald Trump storm the Capitol in Washington, Wednesday, Jan. 6, 2021. A former Republican legislative candidate who traveled to Washington for former President Donald Trump's “Stop the Steal” rally was arrested Friday, July 21, 2023, and charged with federal crimes for his role in the U.S. Capitol riot, officials said. (AP Photo/John Minchillo, File)The Associated Press

PORTLAND, Maine -- A former Republican legislative candidate who traveled to Washington for former President Donald Trump's “Stop the Steal” rally was arrested Friday and charged with federal crimes for his role in the U.S. Capitol riot, officials said.

Matthew Brackley, 39, of Waldoboro, Maine, entered the the Capitol on Jan. 6, 2021, and asked for the location of House Speaker Nancy Pelosi’s office before shouting, “Let’s go," according to prosecutors.

He was arrested on felony charges including assaulting, resisting or impeding certain officers and civil disorder, along with several misdemeanors. He made his initial court appearance on Friday.

It was not clear if Brackley had a lawyer, and he did not immediately respond to an email request for comment.

Brackley tried unsuccessfully to unseat Democratic state Sen. Eloise Vitelli of Arrowsic last year. His campaign website described him as a Maine Maritime Academy graduate whose approach would be to have “respectful, thoughtful conversations on the issues.”

At the Capitol, prosecutors said, Brackley led a group that pushed through police officers several times before ultimately being dispersed by chemical spray and exiting.

More than 1,000 people have been charged with federal crimes related to the Jan. 6 attack.

Approximately 100 of them have been convicted by juries or judges after trials, and more than 600 have pleaded guilty.

Over 570 riot defendants have been sentenced, with more than half receiving prison terms ranging from three days to 18 years.

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

WSS

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Amylyx ALS drug failure raises questions and concerns

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Just how do doctors, lawmakers, and the public define abortion?

Just how do doctors, lawmakers, and the public define abortion?

With psoriasis trial ahead, Alumis raises $259 million

focus

hotspot

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Precocious puberty in girls comes with mental health risks

Wildfire smoke exposes gaps in outdoor worker protections

A deep dive into Applied Therapeutics’ data, and questions on Cassava

As demand for Covid shots wanes, Moderna seeks its next success

UnitedHealth increases loan offers after Change Healthcare outage

Supreme Court strikes down use of affirmative action

Orchard's therapy for neuron disease in children wins FDA approval

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Future doctors should be trained to promote social change

entertainment

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

What it’s like to watch children die of measles

Asbestos, a deadly carcinogen, banned by EPA

Change Healthcare cyberattack prompts Medicare loan program

focus

explore

explore

focus